Home

Xtant Medical Holdings, Inc. Common Stock (XTNT)

0.5905
+0.0005 (0.08%)
NYSE · Last Trade: Dec 1st, 6:53 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Xtant Medical Holdings, Inc. Common Stock (XTNT)

Innovative Medical

Innovative Medical is a newer player in the orthopedic and spine markets, focusing on developing novel solutions and disruptive technologies. Although not as large as Xtant Medical's more prominent competitors, they have carved a niche in specific areas of spinal care, competing on innovation and specialized offerings. Their agility in the market allows them to respond quickly to surgical needs, potentially posing a challeng to more established firms.

Medtronic MDT -1.89%

Medtronic is one of the largest medical device companies in the world and has a significant presence in the spine surgery market, offering a wide range of surgical solutions and implants. They utilize extensive research and development capabilities to create advanced technologies and products, allowing them to lead in innovation. Their broad product range and established distribution channels give them a competitive edge over smaller players like Xtant Medical.

NuVasive

NuVasive focuses specifically on spine surgery products and technologies, emphasizing minimally invasive surgical techniques and innovative products. They compete with Xtant Medical by targeting similar market segments and delivering advanced surgical solutions designed to enhance patient outcomes. NuVasive's emphasis on technology and partnerships with surgeons gives them a slight edge in clinical appeal, although they also face challenges from larger firms.

Stryker Corporation SYK +0.31%

Stryker Corporation is known for its diverse portfolio in medical devices, including orthopedic technologies and spinal surgical instruments. The company invests heavily in innovation and has robust marketing and sales strategies that allow them to capture a significant market share. Stryker's strong global reputation and established product lines provide them with a competitive advantage over Xtant Medical, particularly in larger hospitals and surgical centers.

Zimmer Biomet ZBH -2.83%

Zimmer Biomet boasts a comprehensive line of orthopedic products, including spine, knee, and hip implants, and has a significant market presence worldwide. Their strategy focuses on high-quality implant systems and established relationships with healthcare providers, giving them an advantage in brand recognition. While ZBH's offerings overlap with Xtant Medical's, their scale and extensive distribution networks present substantial competition.